Beijing Foyou Pharma CO.,LTD (SHA:601089)
China · Delayed Price · Currency is CNY 25.54
+0.69 (2.78%)
At close: Dec 4, 2025
SHA:601089 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | 463.07 | 488.67 | 488.77 | 438.9 | 314.47 | 262.71 | Upgrade |
Depreciation & Amortization | 101.43 | 101.43 | 97.76 | 82.85 | 63.25 | 44.22 | Upgrade |
Other Amortization | 5.72 | 5.72 | 7.03 | 1.24 | 0.23 | 5.23 | Upgrade |
Loss (Gain) From Sale of Assets | 1.72 | 1.72 | 1 | -0.14 | -0.01 | 0.65 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | 0.8 | 1.13 | 16.5 | Upgrade |
Loss (Gain) From Sale of Investments | -11.19 | -11.19 | -2.28 | -3.17 | -2.36 | -2.81 | Upgrade |
Provision & Write-off of Bad Debts | 0.72 | 0.72 | -3.48 | 2.08 | -2.53 | - | Upgrade |
Other Operating Activities | -132.01 | 18.21 | 23.24 | 17.33 | 20.1 | 13.24 | Upgrade |
Change in Accounts Receivable | -28.57 | -28.57 | -23.28 | -68.65 | 5.59 | -17.6 | Upgrade |
Change in Inventory | -50.82 | -50.82 | 17.99 | -25.64 | -56.56 | -16.1 | Upgrade |
Change in Accounts Payable | 169.62 | 169.62 | -49.36 | 216.44 | 175.07 | 75.22 | Upgrade |
Change in Other Net Operating Assets | -1.36 | -1.36 | -2.76 | -3.84 | -0.27 | 2.74 | Upgrade |
Operating Cash Flow | 514.92 | 690.75 | 555.9 | 659.76 | 528.02 | 386.65 | Upgrade |
Operating Cash Flow Growth | -18.50% | 24.26% | -15.74% | 24.95% | 36.56% | 28.28% | Upgrade |
Capital Expenditures | -456.07 | -391.52 | -366.08 | -135.4 | -192.97 | -168.96 | Upgrade |
Sale of Property, Plant & Equipment | -8.04 | 1.37 | 0.52 | 0.63 | 0.27 | 2.14 | Upgrade |
Investment in Securities | -1,659 | -1,659 | - | 100 | -50 | - | Upgrade |
Other Investing Activities | 2,528 | 34.56 | -20.1 | 3.37 | 2.56 | -66.02 | Upgrade |
Investing Cash Flow | 405.24 | -2,015 | -385.66 | -31.41 | -240.14 | -232.84 | Upgrade |
Long-Term Debt Issued | - | 49.9 | 55 | 50.45 | 214.27 | 146.2 | Upgrade |
Long-Term Debt Repaid | - | -104.01 | -67.09 | -89.33 | -221.2 | -373.04 | Upgrade |
Net Debt Issued (Repaid) | -71.7 | -54.11 | -12.09 | -38.89 | -6.92 | -226.84 | Upgrade |
Issuance of Common Stock | - | - | - | 1,669 | - | - | Upgrade |
Repurchase of Common Stock | -176.19 | -176.19 | - | - | - | - | Upgrade |
Common Dividends Paid | -234.53 | -236.59 | -194.6 | -111.22 | -114.21 | -119.28 | Upgrade |
Other Financing Activities | 177.29 | -0.02 | - | -25.18 | -18.3 | -0.37 | Upgrade |
Financing Cash Flow | -305.13 | -466.9 | -206.68 | 1,494 | -139.44 | -346.48 | Upgrade |
Net Cash Flow | 615.03 | -1,791 | -36.44 | 2,123 | 148.44 | -192.68 | Upgrade |
Free Cash Flow | 58.85 | 299.23 | 189.82 | 524.36 | 335.05 | 217.69 | Upgrade |
Free Cash Flow Growth | -75.97% | 57.63% | -63.80% | 56.50% | 53.91% | 1.24% | Upgrade |
Free Cash Flow Margin | 1.72% | 8.68% | 5.68% | 16.18% | 11.81% | 8.59% | Upgrade |
Free Cash Flow Per Share | 0.12 | 0.64 | 0.40 | 1.24 | 0.93 | 0.60 | Upgrade |
Cash Income Tax Paid | 346.47 | 311.55 | 377.29 | 310.75 | 280.1 | 229.79 | Upgrade |
Levered Free Cash Flow | -73.05 | 192.89 | -3.46 | 342.84 | 274.68 | 96.66 | Upgrade |
Unlevered Free Cash Flow | -71.82 | 195.08 | -0.12 | 345.82 | 278.74 | 103.6 | Upgrade |
Change in Working Capital | 85.48 | 85.48 | -56.13 | 119.88 | 133.74 | 46.91 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.